Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03079037 · ClinicalTrials.gov registry record
Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 15
- Enrollment target
NCT03079037: Completed study, sponsored by University of Minnesota.
NCT03079037 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03079037 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This study will test the hypothesis that deep brain stimulation (DBS) targeting specific changes in oscillatory activity at the site of stimulation will prove superior to continuous isochronal DBS thus providing the rationale for development and optimization of closed loop paradigms and determine whether the optimal closed-loop biomarker varies across subcortical targets, is task dependent, or serves to re-establish a default network that removes an underlying disruptive physiological state leading to greater improvement in motor signs and task performance.
Primary Outcome
Clinical ratings scales (MDS-UPDRS)
Interventions
- DEVICE Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-06-19 |
| Est. Completion | 2023-01-29 |
What the finished NCT03079037 record still lists
NCT03079037 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Stimulation is the first listed.
NCT03079037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03079037 about?
NCT03079037 is a clinical study titled "Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3". This study will test the hypothesis that deep brain stimulation (DBS) targeting specific changes in oscillatory activity at the site of stimulation will prove superior to continuous isochronal DBS thus providing the rationale for development and optimization of closed loop paradigms and determine wh...
What is the current status of trial NCT03079037?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2018-06-19. Estimated completion is 2023-01-29.
What interventions are being tested in trial NCT03079037?
The interventions under investigation include: Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03079037?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI